Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | SLC26A3 |
| Upstream (Parents) |
|---|
| (<<) FCN2 → SLC26A3 |
| (<<) ELOVL5 → SLC26A3 |
| (<<) AKR1D1 → SLC26A3 |
| (<<) ACSM1 → SLC26A3 |
| (<<) UGT2B28 → SLC26A3 |
| (<<) ALOX15B → SLC26A3 |
| Downstream (Children) |
|---|
| SLC26A3 → ZNF689 (>>) |
| SLC26A3 → MYOM2 (>>) |
| SLC26A3 → SYCP1 (>>) |
| SLC26A3 → ATP13A4 (>>) |
| SLC26A3 → AKR1D1 (>>) |
| SLC26A3 → SULT1C4 (>>) |
| SLC26A3 → ECHDC2 (>>) |
| SLC26A3 → CCDC15 (>>) |
| SLC26A3 → SEPP1 (>>) |
| SLC26A3 → ACSM1 (>>) |
| SLC26A3 → HPGD (>>) |
| SLC26A3 → CXCL6 (>>) |
